REDHILL BIOPHARMA SUCCESSFULLY REGAINS COMPLIANCE WITH NASDAQ STOCKHOLDERS' EQUITY REQUIREMENT
REDHILL BIOPHARMA SUCCESSFULLY REGAINS COMPLIANCE WITH NASDAQ STOCKHOLDERS' EQUITY REQUIREMENTView original